As of 2026-05-04, the Fair Value of Telix Pharmaceuticals Ltd (TLX.AX) is -0.53 AUD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 15.57 AUD, the upside of Telix Pharmaceuticals Ltd is -103.37%.
With the market price of 15.57 AUD and our fair value calculation, Telix Pharmaceuticals Ltd (TLX.AX) is not a good investment. Investing in TLX.AX stocks now will result in a potential loss of 103.37%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -80.51 | -67.50 | 4.21 | 33.69 | -7.12 | -23.45 |
| YoY growth | -79.36% | 16.17% | 106.23% | 700.50% | -121.15% | 124.48% |
| Market Cap (mil) | 5,279.94 |
| P/E | |
| Forward P/E | 356.17x |
| EPS | -0.02 |
| Avg earnings growth rate | 124.48% |
| TTM earnings | -7.12 |